"IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ"
NCT07503834
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Transplant
Interventions
DRUG:
Anakinra 100Mg/0.67Ml Inj Syringe
Sponsor
Nantes University Hospital